228 related articles for article (PubMed ID: 12705632)
1. Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing.
Chen Y; Rittling SR
Clin Exp Metastasis; 2003; 20(2):111-20. PubMed ID: 12705632
[TBL] [Abstract][Full Text] [Related]
2. Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.
Natasha T; Kuhn M; Kelly O; Rittling SR
Am J Pathol; 2006 Feb; 168(2):551-61. PubMed ID: 16436669
[TBL] [Abstract][Full Text] [Related]
3. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
Aldaz CM; Liao QY; LaBate M; Johnston DA
Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
[TBL] [Abstract][Full Text] [Related]
4. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
[TBL] [Abstract][Full Text] [Related]
5. Animal models of bone metastasis.
Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.
Wu Y; Denhardt DT; Rittling SR
Br J Cancer; 2000 Jul; 83(2):156-63. PubMed ID: 10901364
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.
Jessen KA; Liu SY; Tepper CG; Karrim J; McGoldrick ET; Rosner A; Munn RJ; Young LJ; Borowsky AD; Cardiff RD; Gregg JP
Breast Cancer Res; 2004; 6(3):R157-69. PubMed ID: 15084239
[TBL] [Abstract][Full Text] [Related]
8. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
9. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL
Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues.
Nemoto H; Rittling SR; Yoshitake H; Furuya K; Amagasa T; Tsuji K; Nifuji A; Denhardt DT; Noda M
J Bone Miner Res; 2001 Apr; 16(4):652-9. PubMed ID: 11315992
[TBL] [Abstract][Full Text] [Related]
12. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
14. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
Shin SR; Sánchez-Velar N; Sherr DH; Sonenshein GE
Cancer Res; 2006 Mar; 66(5):2570-5. PubMed ID: 16510574
[TBL] [Abstract][Full Text] [Related]
15. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations.
Abba MC; Zhong Y; Lee J; Kil H; Lu Y; Takata Y; Simper MS; Gaddis S; Shen J; Aldaz CM
Oncotarget; 2016 Sep; 7(39):64289-64299. PubMed ID: 27588403
[TBL] [Abstract][Full Text] [Related]
16. Colonization characteristics of a murine mammary tumor cell line that metastasizes frequently to the heart.
Hossain A; Sarkar NH
Clin Exp Metastasis; 1991; 9(4):351-61. PubMed ID: 1868627
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
18. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines.
Morris VL; Tuck AB; Wilson SM; Percy D; Chambers AF
Clin Exp Metastasis; 1993 Jan; 11(1):103-12. PubMed ID: 8422701
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines.
Ono K; Akatsu T; Murakami T; Kitamura R; Yamamoto M; Shinomiya N; Rokutanda M; Sasaki T; Amizuka N; Ozawa H; Nagata N; Kugai N
J Bone Miner Res; 2002 May; 17(5):774-81. PubMed ID: 12009007
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of clonal cell lines from a transplantable metastasizing rat mammary tumor, TR2CL.
Williams JC; Gusterson BA; Monaghan P; Coombes RC; Rudland PS
J Natl Cancer Inst; 1985 Feb; 74(2):415-28. PubMed ID: 2579259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
